Neurology News and Research

Latest Neurology News and Research

Scientists find link between early-onset Parkinson's and 22q11.2 deletion syndrome

Scientists at the Centre for Addiction and Mental Health (CAMH) and University Health Network (UHN) have found a new link between early-onset Parkinson's disease and a piece of DNA missing from chromosome 22. The findings help shed new light on the molecular changes that lead to Parkinson's disease.

10 Sep 2013

Degeneration of fornix in brain may provide clues to future cognitive decline in healthy old people

The degeneration of a small, wishbone-shaped structure deep inside the brain may provide the earliest clues to future cognitive decline, long before healthy older people exhibit clinical symptoms of memory loss or dementia, a study by researchers with the UC Davis Alzheimer's Disease Center has found.

10 Sep 2013

European launch of new version of REVIVE™ SE Thrombectomy Device for treatment of acute ischemic stroke announced by Codman Neuro

Codman Neuro*, part of DePuy Synthes Companies of Johnson & Johnson, announced the European launch of the REVIVE™ SE Thrombectomy Device, a next generation clot removal device offering enhanced navigation through the cerebral vasculature and rapid restoration of blood flow to the brain after an ischemic stroke.

9 Sep 2013

Biogen Idec And Isis Ink Fourth Deal In Two Years

...

9 Sep 2013

Social media and online communities can improve health behaviors among men at risk of HIV

A UCLA study published Sept. 3 in the peer-reviewed journal Annals of Internal Medicine demonstrates that an approach that combines behavioral science with social media and online communities can lead to improved health behaviors among men at risk of HIV infection.

7 Sep 2013

Self-propagating aggregates key to Alzheimer's, other diseases

Two leading neurology researchers have proposed a theory that could unify scientists' thinking about several neurodegenerative diseases and suggest therapeutic strategies to combat them.

6 Sep 2013

Golgi apparatus: New target for treatment of acute cerebral infarction

Expression of soluble CD40L has been shown to increase sig-nificantly in conditions such as stroke, myocardial infarction, unstable angina, high cholesterol, or other cardiovascular events. 95% of the circulating CD40L exists in activated platelets.

5 Sep 2013

GW SMHS announces two-year Neurology Health Policy Research Fellowship

The George Washington University School of Medicine and Health Sciences, in partnership with the GW School of Public Health and Health Services, is pleased to announce a two-year Neurology Health Policy Research Fellowship, sponsored primarily by the American Academy of Neurology in collaboration with the American Neurological Association and the Child Neurology Society.

5 Sep 2013

Elan enrolls first patient dosing in phase 2a study of ELND005 in Down syndrome

Elan Corporation, plc (NYSE: ELN) announced today the first patient dosing in a Phase 2a study of ELND005 in Down syndrome. Study ELND005-DS201 will evaluate the safety and pharmacokinetics of 2 doses of ELND005 and placebo in young adults with Down syndrome without dementia, and will also include select cognitive and behavioural measures.

5 Sep 2013

PET imaging predicts favorable outcome after decompressive surgery in patients with cervical myelopathy

For patients with degenerative cervical myelopathy, imaging with 18F-FDG positron emission tomography (PET) could act as a marker for a potentially reversible phase of the disease in which substantial clinical improvement can be achieved.

5 Sep 2013

Research: Men who exercise vigorously may reduce risk of epilepsy later in life

New research suggests that men who exercise vigorously as young adults may reduce their risk of developing epilepsy later in life. The study is published in the September 4, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology. Epilepsy is a brain disease that causes repeated seizures over time.

5 Sep 2013

Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia

Resveratrol, a polyphenolic compound, is synthesized in several plants and possesses beneficial biological effects, which include anti-oxidant, anti-inflammatory and anti-carcinogenic properties.

5 Sep 2013

Scientists identify new drugs that have potential to slow down progression of Parkinson's

New drugs which may have the potential to stop faulty brain cells dying and slow down the progression of Parkinson's, have been identified by scientists in a pioneering study which is the first of its kind.

4 Sep 2013

More young people show risk factors for common type of strokes

Fifteen percent of the most common type of strokes occur in adolescents and young adults, and more young people are showing risk factors for such strokes, according to a report in the journal Neurology.

4 Sep 2013

Prana's PBT2 drug recognised as one of the most promising treatments under development

Prana Biotechnology, a leading global developer of first-in-class treatments for neurodegenerative disease, is pleased to announce Elsevier Business Intelligence has named clinical drug PBT2 as one of the Top 10 Neuroscience Projects to Watch.

3 Sep 2013

Ipsen announces results of phase III study of somatuline in patients with neuroendocrine tumors

Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the detailed results of phase III CLARINET study assessing the effect of Somatuline® Autogel® 120 mg in patients with gastrointestinal and pancreatic neuroendocrine tumors ("GEP-NETs")1 will be disclosed for the first time on September 28, 2013 at the European Cancer Congress 2013 (Sept. 27 - Oct. 1, 2013) in Amsterdam.

31 Aug 2013

Neurology News and Research

Latest Neurology News and Research

Scientists find link between early-onset Parkinson's and 22q11.2 deletion syndrome

Degeneration of fornix in brain may provide clues to future cognitive decline in healthy old people

European launch of new version of REVIVE™ SE Thrombectomy Device for treatment of acute ischemic stroke announced by Codman Neuro

Biogen Idec And Isis Ink Fourth Deal In Two Years

Social media and online communities can improve health behaviors among men at risk of HIV

Self-propagating aggregates key to Alzheimer's, other diseases

Golgi apparatus: New target for treatment of acute cerebral infarction

GW SMHS announces two-year Neurology Health Policy Research Fellowship

Elan enrolls first patient dosing in phase 2a study of ELND005 in Down syndrome

PET imaging predicts favorable outcome after decompressive surgery in patients with cervical myelopathy

Research: Men who exercise vigorously may reduce risk of epilepsy later in life

Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia

Scientists identify new drugs that have potential to slow down progression of Parkinson's

More young people show risk factors for common type of strokes

Prana's PBT2 drug recognised as one of the most promising treatments under development

Ipsen announces results of phase III study of somatuline in patients with neuroendocrine tumors

Mayo Clinic tests feasibility of telemedicine robot to assess athletes during football games

EEG marker unlikely to predict epilepsy death

European Commission approves Stivarga tablets for treatment of patients with mCRC

NIHR recognizes Plymouth Hospitals for promoting clinical research in NHS

Neuroscience - Third Edition eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Neurology News and Research

Latest Neurology News and Research

Neuroscience - Third Edition eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in